 BURLINGAME, Calif., Aug. 02, 2021 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. Nasdaq: CRVS, a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the second quarter ended June 30, 2021. 